← Eichor
Study identifier: NCT05851391 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

Condition: Hypoxia-Ischemia, Brain · Heart Arrest · Status Epilepticus  ·  Sponsor: University of California, San Francisco

PhasePhase 2
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Edilberto Amorim, MD  ·  628-206-3203  ·  restorestudy@ucsf.edu

Kevin Bao  ·  (415)514-2120  ·  restorestudy@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Zuckerberg San Francisco General HospitalSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05851391